跳至主要内容
临床试验/IRCT20200203046351N1
IRCT20200203046351N1招募中3 期

Role of topical tranexamic acid in reducing perioperative blood loss in traumatic and non-traumatic patients undergoing posterior lumbar spinal surgery

Bagheiat-allah University of Medical Sciences0 个研究点目标入组 104 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
104

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Patients with age between 18 to 75 years .
  • Patients whom needs posterior lumbar spinal surgery
  • Traumatic patients ( in the first 3 weeks after injury)
  • Non-traumatic patients (with maximum 4 spinal level envolved)

排除标准

  • History of thromboembolism
  • Emergent surgery with indications other than neurosurgical indications
  • Treatment with other drugs that affect blood coagulation such as sodium valproate
  • Any transexamic acid intake before (eg polymenorrhea in women or in dentistry)
  • Treatment with anticoagulants
  • Treatment with antiplatelets
  • Spinal penetrating injury
  • Hemodynamical unstability
  • History of epilepsy or seizure
  • Liver malfunction
  • Renal failure
  • Abnormal results of laboratory coagulation tests
  • Patient's reluctance

研究者

发起方
Bagheiat-allah University of Medical Sciences

相似试验

topical tranexamic acid in perioperative blood loss... | 临床试验